<
 
 
 
 
×
>
hide
You are viewing a Web site, archived on 01:50:02 Dec 06, 2014. It is now a Federal record managed by the National Archives and Records Administration.
External links, forms, and search boxes may not function within this collection.

Hearing on “21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development," Subcommittee on Health (September 19, 2014)

Subcommittee on Health (113th Congress)
Sep 19, 2014
2123 Rayburn House Office Building

The Subcommittee on Health held a hearing on Friday, September 19, 2014, at 9:00 a.m. in 2123 Rayburn House Office Building.  The hearing was titled “21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development."

Documents

Memorandum from Ranking Member Henry A. Waxman to Democratic Members of the Subcommittee on Health

Opening Statement of Ranking Member Henry A. Waxman, as prepared for delivery.

Preliminary Transcript

 

Witnesses

Panel I
Dr. Janet Woodcock
Director, Center for Drug Evaluation and Research
U.S. Food and Drug Administration (FDA)
Testimony

Panel II
Dr. Kenneth J. Hillan
Chief Executive Officer
Achaogen, Inc.
Testimony

Dr. Barbara E. Murray
President
Infectious Diseases Society of America
Testimony

Kevin Outterson
Professor of Law
Boston University School of Law
Testimony

Dr. Adrian Thomas
Vice President, Global Market Access and Public Health
Janssen Global Services, LLC
Testimony

Allan Coukell
Director, Medical Programs, Pew Health Group
The Pew Charitable Trusts
Testimony

Dr. John H. Powers
Assistant Clinical Professor of Medicine
George Washington University School of Medicine
Testimony

 

Webcast

Key Documents: 
113th Congress